Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a pill speed up hip fracture recovery in seniors?

NCT ID NCT02578095

Disease control Sponsor: Viking Therapeutics, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called VK5211 in 108 adults aged 65 and older who had recently broken a hip. The goal was to see if the drug could help rebuild muscle mass lost after the injury. Participants took the drug or a placebo daily for 12 weeks, and researchers measured changes in body composition using a special X-ray scan.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
VK5211
What this could lead to
If it works, this could lead to a treatment that helps older adults regain muscle and recover faster after a hip fracture.
What could go wrong
This is an early phase 2 trial with only 108 people, so results may not apply to everyone. The drug may not improve real-world recovery like walking or daily activities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

108 people

The number who actually took part.

Started

Oct 2015

Finished

Dec 2017

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males or females ≥65 years old who are recovering from a hip fracture (occurring 3-7 weeks prior) with no residual surgical issues will be eligible for participation. Exclusion Criteria: * Pathological fracture (e.g. fracture due to Paget's disease of bone, malignancy, etc.). Fracture due to postmenopausal osteoporosis is not considered pathological for this trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fractures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip fractures

Contacts and locations

Locations

  • Center for Advanced Research & Education

    Gainesville, Georgia, 30501, United States

  • Clinical Center Kragujevac Department for Orthopedics and Traumatology

    Kragujevac, 34000, Serbia

  • Clinical Centre of Vojvodina Department for Orthopedic Surgery and Traumatology

    Novi Sad, 21000, Serbia

  • Duurga Clinical Service

    Yorba Linda, California, 92886, United States

  • Hospital Center "Bezanijska kosa" Department for Orthopedic Surgery and Traumatology

    Belgrade, 11080, Serbia

  • Infinite Clinical Research

    Doral, Florida, 33126, United States

  • Institut za Ortopedsko-hirurške bolesti Banjica

    Belgrade, 11000, Serbia

  • Jósa András Oktató Kórház Traumatológiai és Kézsebészeti Osztály

    Nyíregyháza, 4400, Hungary

  • Klinički Centar Srbije

    Belgrade, 11000, Serbia

  • MH Egészségügyi Központ Baleseti Sebészeti Osztály

    Budapest, Hungary

  • Orthopaedic Association of Michigan

    Grand Rapids, Michigan, 49525, United States

  • Orthopedic Research Institute

    Boynton Beach, Florida, 33472, United States

  • Petz Aladár Megyei Oktató Kórház Mozgásszervi Rehabilitációs Osztály

    Győr, 9024, Hungary

  • SZTE ÁOK Traumatológiai Klinika

    Szeged, 6725, Hungary

  • Shrock Orthopedic Research, LLC

    Fort Lauderdale, Florida, 33136, United States

  • Spitalul Clinic Judeţean de Urgenţe, Sfȃntul Spiridon

    Iași, 700111, Romania

  • Spitalul Clinic de Urgenta Bucuresti ("Floreasca")

    Bucharest, 014461, Romania

  • Spitalul Universitar de Urgenţă

    Bucharest, 050098, Romania

  • Szent János Kórház és Észak budai Egyesített Kórházak Traumatológiai és Kézsebészeti Osztály

    Budapest, 1125, Hungary

  • Szent Margit Kórház, Mozgásszervi Rehabilitációs Osztály

    Budapest, Hungary

  • University of Wisconsin Osteoporosis Clinical Research Program

    Madison, Wisconsin, 53705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.